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 The prevalence of cardiorespiratory fitness (CRF) non-response gradually 
declines in healthy individuals exercising 60, 120, 180, 240 or 300 min per 
week for 6 weeks.   
 Following a successive identical 6-week training period but comprising 120 
min of additional exercise per week, CRF non-response is universally 
abolished. 
 The magnitude of CRF improvement is primarily attributed to changes in 
hemoglobin mass. 
 The potential for CRF improvement may be present and unveiled with 
appropriate exercise training stimuli in healthy individuals without exception. 
Abstract  One in five adults following physical activity guidelines are reported not 
demonstrating any improvement in cardiorespiratory fitness (CRF). Herein, we sought 
to establish whether CRF non-response to exercise training is dose-dependent, using 
a between- and within-subject study design. Seventy-eight healthy adults were 
divided into 5 groups (‗1‘, ‗2‘, ‗3‘, ‗4‘ and ‗5‘) respectively comprising 1, 2, 3, 4 and 
5×60 min exercise sessions per week but otherwise following an identical 6-week 
endurance training (ET) program. Non-response was defined as any change in CRF, 
determined by maximal incremental exercise power output (Wmax), within the typical 
error of measurement (±3.96%). Participants classified as non-responders after the ET 
intervention completed a successive 6-week ET period including 2 additional exercise 
sessions per week. Maximal oxygen consumption (VO2max), haematology and muscle 
biopsies were assessed prior to and after each ET period. After the first ET period, 
Wmax increased (P < 0.05) in groups ‗2‘, ‗3‘, ‗4‘ and ‗5‘, but not ‗1‘ . In groups ‗1‘, ‗2‘, ‗3‘, 
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‗4‘ and ‗5‘, 69%, 40%, 29%, 0% and 0% of individuals, respectively, were non-
responders. After the second ET period, non-response was eliminated in all 
individuals. The change in VO2max with exercise training independently determined 
Wmax response (partial correlation coefficient (rpartial ≥ 0.74, P < 0.001). In turn, total 
hemoglobin mass was the strongest independent determinant of VO2max (rpartial= 0.49, 
P < 0.001). In conclusion, individual CRF non-response to exercise training is 
abolished by increasing the dose of exercise and primarily a function of 
haematological adaptations in oxygen-carrying capacity.  
Abbreviations  BV, blood volume; CO, carbon monoxide; CRF, cardiorespiratory fitness; ET, endurance 
training; [Hb], haemoglobin concentration; Hbmass, haemoglobin mass; Hct, haematocrit; HRmax, 
maximal heart rate; MitoVD, mitochondrial volume density; PV, plasma volume; RBCV, red blood cell 
volume; TE, typical error of measurement; VO2max, maximal oxygen consumption; Wmax, maximal power 
output. 
Introduction 
Primary sources regarding the notion of physical activity as a means to preserve 
health emerged along with the inception of scientific medicine in ancient Greece 
(ACSM, 2013). More than 2 millennia later, outstanding health benefits associated 
with physical activity have been demonstrated by modern experimental, 
epidemiological and clinical sciences (Morris et al., 1953; Lee et al., 1995; Church et 
al., 2007; Wen et al., 2011; Pedersen & Saltin, 2015). Daily vigorous exercise 
decreases cardiovascular, metabolic and all-cause mortality by 40 to 70 %, 
irrespective of age, gender and presence of disease (Wen et al., 2011). Many of these 
benefits are closely associated with improvements in cardiorespiratory fitness (CRF), 
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as determined by maximal oxygen consumption (VO2max) or incremental exercise 
power output (Wmax), independent of traditional risk factors (Joyner & Green, 2009; 
Lee et al., 2010). CRF is thus considered a key surrogate endpoint of exercise training 
interventions in healthy and diseased individuals (Laukkanen et al., 2001; Kodama et 
al., 2009).  
Among exercise training modalities, CRF is particularly responsive to endurance 
training (ET). VO2max and Wmax commonly increase by an average of ~3-35 % at the 
group level with regular ET in a dose (exercise duration × intensity)-dependent 
manner (Wenger & Bell, 1986; Church et al., 2007; Helgerud et al., 2007; Bouchard et 
al., 2011b; Bacon et al., 2013; Jacobs et al., 2013; Bonne et al., 2014; Montero et al., 
2015a). VO2max and Wmax gains induced by a given dose of supervised ET are however 
not uniform at the individual level, one third of measurements being dispersed more 
than one standard deviation from the mean (Cohen & Holliday, 1979; Lortie et al., 
1984; Bouchard et al., 2011b; Bacon et al., 2013). Importantly, some individuals do 
seemingly not demonstrate any improvement in VO2max with ET according to current 
dose recommendations (150 minutes of moderate endurance exercise per week) 
(Bouchard et al., 2011b; Garber et al., 2011). The prevalence of VO2max non-
responders has been reported to reach up to 20 % among healthy individuals 
(Timmons et al., 2010), raising compelling challenges to personalized preventive 
medicine (Buford et al., 2013).  
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As a first step, it is fundamental to understand which factors contribute to 
interindividual differences in CRF trainability. In this regard, much attention has been 
paid to genetic determinants (Bouchard et al., 1999; Timmons et al., 2010; Bouchard 
et al., 2011a; Bouchard et al., 2011b; Bouchard, 2012; Sarzynski et al., 2016). Herein, 
21 single-nucleotide polymorphisms were found to explain up to 50 % of the VO2max 
individual response to 5 months of moderate ET in a cohort of 473 sedentary adults 
from the HERITAGE Family Study (HERITAGE henceforward) (Bouchard et al., 2011b). 
Approximately 8 % of these individuals increased VO2max by 28 % or more, whereas 
~7 % demonstrated a change in VO2max of only 4 % or less (Bouchard et al., 2011b). 
While these findings have to be replicated, the notion has spread that CRF trainability 
is essentially a matter of fate (Roth, 2008; Bouchard, 2012; Mosley, 2012). Yet, it is 
uncertain whether HERITAGE outcomes can be extrapolated to at-risk or diseased 
populations and above all, it remains to be established whether or to what extent 
CRF non-response is dose-dependent.  
The influence of ET dose on CRF non-response was recently examined in 3 groups of 
obese adults exposed to 3 distinct levels of exercise amount and intensity for 6 
months (Ross et al., 2015). CRF non-response, as defined by any change in VO2max 
lower than the typical error of measurement (TE), was observed in 39, 18 and 0 % of 
obese individuals respectively randomized to low-amount (180-300 kcal·session-
1)/low-intensity (50 % VO2max), high-amount (360-600 kcal·session
-1)/low-intensity (50 
% VO2max) or high-amount (360-600 kcal·session
-1)/high-intensity (75 % VO2max) ET, 
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all including 4-5 exercise sessions per week (Ross et al., 2015). A similar decline in the 
prevalence of VO2max non-responders was previously demonstrated in 
postmenopausal women allocated to 4-5 exercise sessions requiring 4, 8 or 12 
kcal·kg-1 per week during 6 months (Sisson et al., 2009). These studies therefore 
suggest that CRF non-response might ultimately be the result of inadequate exercise 
stimuli. Nonetheless, it should be noted that only individuals who adhered to at least 
90% of the prescribed exercise sessions were included in these analyses (Sisson et al., 
2009; Ross et al., 2015). It thus cannot be discarded that non-responders were 
primarily excluded by study design. To unequivocally overcome this issue, CRF non-
responders should first be identified and then subjected to higher dose ET (Mann et 
al., 2014). This may be ideally addressed using a repeated ET intervention, which 
likewise would limit the influence of within-subject response variability, a well-known 
source of confounding in the clinical arena but uncertain concerning exercise training 
studies (Senn et al., 2011; Hecksteden et al., 2015).  
Therefore, we assessed the response of CRF to ET in healthy young individuals 
divided into 5 groups comprising 1, 2, 3, 4 or 5 × 60 min exercise sessions) per week 
during 6 weeks. We used this relatively short length of ET in order to secure a high 
prevalence of CRF non-responders while still provoking extensive physiological 
responses at the group level (Montero et al., 2015a). Likewise, Wmax was chosen  as 
the primary CRF outcome because its TE, as measured in our laboratory, is lower 
compared with that frequently reported for VO2max (~ 5 %) (Shephard et al., 2004); 
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indeed, the relatively large contribution of test–retest errors in VO2max to the 
individual response to ET has been a matter of controversy concerning seminal 
studies in the current topic (Shephard et al., 2004; Hecksteden et al., 2015). 
Individuals identified as non-responders subsequently completed an identical 6-week 
ET period but including 2 additional exercise sessions per week, thereby augmenting 
the ET dose dispensed. In addition, VO2max as well as potential haematological and 
skeletal muscle determinants of Wmax were assessed prior to and after each ET period 
with the intent to determine physiological relevant parameters that may explain 
variations in trainability. 
Methods 
Participants 
Seventy-eight healthy young males volunteers (age = 26.2 ± 3.4 yr, height = 180.8 ± 
4.3 cm) were recruited to participate in the study. To this end, ads were placed at the 
university campus looking for untrained individuals. As inclusion criteria, individuals 
had to be to males between 18-35 years old not participating in organized sports, 
non-smokers and medication free. Cycling and walking for commuting purposes was 
allowed. The protocol was approved by the local ethical committee (EK 2011-N-51) 
and conducted in accordance with the Declaration of Helsinki. Prior to the start of the 
experiments, informed oral and written consents were obtained from all participants. 
Experimental design 
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All individuals underwent a first period of supervised training for 6 weeks consisting 
of 60 min sessions of cycle ergometer exercise. Individuals could chose to participate 
in 5 groups differing in the number of exercise sessions per week. Groups ‗1‘, ‗2‘, ‗3‘, 
‗4‘ and ‗5‘ performed 1, 2, 3, 4 and 5 exercise sessions per week, respectively, 
corresponding to 60, 120, 180, 240 and 300 total min per week. Four different 
intensity profiles, comprising moderate continuous exercise and high-intensity 
intervals were alternated to facilitate participant motivation and compliance, as 
detailed previously (Robach et al., 2014). Profile 1 consisted of a steady-state 
exercise, i.e. 60 min at 65 % of peak power output (Wmax) attained with the 
incremental exercise test. Profile 2 started with 11.25 min at 65 % of Wmax followed 
by 0.5^130, 1.25^50, 0.5^130, 1^50, 11.25^65, 0.5^130, 1.25^50, 0.5^130, 1.25^50, 
0.5^130, 1^50, 11.25^65, 0.5^130, 1.25^50, 0.5^130, 1.25^50, 0.5^130, 1.25^50, 
0.5^130, 1^50 and 11.25^65. Profile 3 started with 3 min at 50 % of Wmax followed 
by 3^60, 3^65, 3^70, 3^75, 3^70, 3^65, 3^60, 3^50, 3^65, 3^50, 3^60, 3^65, 3^70, 
3^75, 3^70, 3^65, 3^60, 3^50 and 3^65. Profile 4 started with 6 min at 65 % of Wmax 
followed by 4^75, 6^65, 4^75, 6^65, 4^75, 6^65, 4^75, 6^65, 4^75, 6^65 and 4^75. 
Each profile had an average exercise intensity of 65% of Wmax for 60 min.  Workloads 
were calculated from individual Wmax determined during the incremental exercise test 
at baseline. CRF non-response was determined using the TE (Hopkins, 2000). TE is a 
measure of technological error and day-to-day biological variation. TE was calculated 
by the standard error of within-subject standard deviation from duplicate Wmax 
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assessments, and expressed as a percent of the individual's mean Wmax (i.e., in the 
form of a coefficient of variation). Any percentage change in Wmax not beyond ± 1 × 
%TE was considered a non-response. Based on repeated testing at baseline in all 
individuals, CRF non-response was calculated to be ± 3.96 % for Wmax. The average 
of duplicate Wmax assessments was considered the baseline Wmax for each individual. 
Less than 7 days after the end of the initial ET period, non-responders in each 
exercise group started a second 6-week ET program identical to the former but 
adding 2 exercise sessions per week. The measures described below were 
determined prior to and after the first ET period as well as following the second ET 
period.  
 
Experimental measures 
 
Incremental exercise test. Wmax and VO2max were determined on an electronically 
braked bicycle ergometer (Monark, Sweden) with continuous measurements of VO2 
using an online gas collection system (Innocor M400, Innovision, Denmark). The test 
started with a warm-up period of 5 min at 50-150 W workloads. Thereafter, the 
workload was increased by 30 W every 60- s until exhaustion. The gas analysers and 
the flowmeter of the applied spirometer were calibrated prior to each test. Breath-
by-breath values were averaged over 30 s. The highest average value was taken as 
the VO2max provided that standard criteria were fulfilled (American Thoracic Society, 
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2003). Wmax was calculated as Wcompl+30· (t/60); Wcompl is the last fully completed 
workload and t is the number of seconds in the final workload.  
Blood. Haemoglobin mass (Hbmass) was measured as previously described 
(Siebenmann et al., 2015), using a modified version of the carbon monoxide (CO) re-
breathing technique (Burge & Skinner, 1995). All individuals rested for 20 min in a 
semi-recumbent position before each measurement. Thereafter, 2 ml of blood was 
sampled from an antecubital vein via a 20-G venflon (BD, USA) and analysed 
immediately in quadruplicate for (i) percent carboxyhaemoglobin and Hb 
concentration ([Hb]) using a hemoximeter (ABL800, Radiometer, Denmark), and (ii) 
haematocrit (Hct) with the micromethod (4 min at 13500 rpm). Subsequently, the 
subject breathed 100 % oxygen for 4 min to flush the nitrogen from the airways. 
After closing the oxygen input, a bolus 1.5 ml/kg of 99.997 % chemically pure CO 
(CO N47, Air Liquide, France) was administrated into the breathing circuit. The 
subjects rebreathed this gas mixture for 10 min. Then, an additional 2 ml blood 
sample was obtained and analysed in quadruplicate. The change in percent 
carboxyhaemoglobin was used to calculate Hbmass, taking into account the amount of 
CO that remained in the rebreathing circuit at the end of the procedure (2.2 
%).(Burge & Skinner, 1995) Total red blood cell volume (RBCV), blood volume (BV) 
and plasma volume (PV) were derived from measures of Hbmass and Hct (Burge & 
Skinner, 1995).  
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Skeletal muscle biopsies. Using the Bergström technique (Bergstrom, 1962) with a 
needle modified for suction, skeletal muscle biopsies from m. vastus lateralis were 
obtained under local anaesthetics while the subject was at rest with a minimum of 24 
h following the last exercise training bout. The biopsy specimen was dissected free of 
fat and connective tissue, divided into sections and immediately prepared for 
analysis as stated below.   
Mitochondrial volume density (MitoVD). Four 1 mm
3 pieces of each muscle biopsy were 
fixed in 2.5% glutaraldehyde at room temperature and processed according to 
standard electron-microscopy protocols. TEM images were obtained in a FEI Tecnai 
G2 Spirit electron microscope (FEI, USA) with an Orius SC1000 CCD camera (Gatan, 
USA) and interfaced with the TEM User software from FEI (FEI, USA). Two hundred 
and sixteen images per biopsy were acquired in a random systematic order from 24 
meshes distributed on 8 grids from 4 blocks.  The Cavalieri feature in the Stereo-
Investigator software (MBF Bioscience, USA) was used to estimate mitochondrial 
volume density (MitoVD) by point counting (West, 2012). The grid spacing was 1 µm 
along both x- and y-axis. Mitochondria boundaries were recognized at the 8200x 
magnification. Each point was assigned as either mitochondria, muscle or ―nothing‖. 
MitoVD was expressed as the percentage of muscle tissue occupied by mitochondria. 
MitoVD was not assessed after the second training period. 
Statistical analysis  
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Statistical analyses were performed using SPSS 22.0 (SPSS, Chicago, USA). Data were 
tested for normal distribution with the Kolmogorov-Smirnov test and for 
homogeneity of variances with Levene‘s test. One-way ANOVA with Bonferroni 
correction for multiple comparisons was used to compare continuous baseline 
variables among groups. To examine the impact of the frequency of exercise sessions 
on the effects of exercise training, a one-way ANOVA was applied including baseline 
values as covariates and Bonferroni correction for multiple comparisons. When F was 
significant in the ANOVA, planned pair-wise specific comparisons were carried out. 
Effects of exercise training on studied variables in each group were assessed by 
paired t-tests. The proportion of CRF non-responders was compared among groups 
with the Chi-Square test. Finally, multiple regression analysis was used to identify 
variables independently associated with absolute changes (post training minus pre 
training, ∆) in Wmax or VO2max, including first and second ET periods. Variables 
significantly associated with ∆Wmax or ∆VO2max in univariate analyses, as determined 
by Pearson‘s correlation coefficients, were entered into the regression model as 
independent variables. In case of high correlation between independent variables, 
each of these were separately entered into the regression model in order to avoid 
high multicollinearity (variance inflation factor >10). A two-tailed P-value less than 
0.05 was considered significant. Data are reported as mean (± SD) unless otherwise 
stated. 
Results  
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Baseline   
Characteristics of study groups prior to ET are summarized in Table 1. Body weight, 
haematological (Hct, Hb, Hbmass, PV, RBCV, BV), skeletal muscle MitoVD and VO2max 
were similar between groups (P > 0.05). The only difference between groups was 
observed with regard to Wmax, which was higher in group ‗5‘ compared with group ‗3‘ 
either as expressed in absolute (W) or relative (W·kg-1) units (P < 0.05). 
First exercise training period 
Table 2 presents absolute changes (Δ) after the first ET period in each group. A 
decrease in body weight with training was only observed in groups ‗4‘ and ‗5‘ (P < 
0.05). MitoVD increased in all groups (P < 0.05). Hbmass, RBCV, BV, VO2max and Wmax 
increased in groups all groups (P < 0.05) except for group ‗1‘. With respect to the 
comparisons of Δ among groups,  Δ body weight was lower (negative) in group ‗5‘ 
compared with groups ‗1‘, ‗2‘ and ‗3‘ (P < 0.05). Moreover, Δ MitoVD was higher in 
groups ‗4‘ and ‗5‘ versus groups ‗1‘ and ‗2‘ (P < 0.05). Δ Hbmass, Δ RBCV, Δ BV and Δ 
VO2max were higher in group ‗5‘ compared with any other group (P < 0.05). Δ Wmax 
was higher in groups ‗4‘ and ‗5‘ versus groups ‗1‘, ‗2‘ and ‗3‘ (P < 0.05). Analyses with 
percentage (instead of Δ) changes and/or without covariate adjustment gave similar 
results. Figure 1 illustrates individual percentage changes in Wmax after the first ET 
period. The prevalence of Wmax non-response was 69 % (11 of 16 individuals), 40 % (6 
of 15), 29 % (4 of 14), 0 % (0 out of 17) and 0 % (0 out of 16) for ‗1‘, ‗2‘, ‗3‘, ‗4‘ and ‗5‘ 
groups, respectively (P < 0.001). The average percentage change in Wmax of non-
  
 
This article is protected by copyright. All rights reserved. 
14 
 
responder individuals was -1 %, -1 % and 2 % for ‗1‘, ‗2‘, ‗3‘ groups, respectively. 
Whilst not measured in the current study, provided a TE for VO2max of 5 % (Shephard 
et al., 2004), the prevalence of VO2max non-response would be 81 % (13 of 16 
individuals), 47 % (7 of 15), 50 % (7 of 14), 18 % (3 out of 17) and 0 % (0 out of 16) 
for ‗1‘, ‗2‘, ‗3‘, ‗4‘ and ‗5‘ groups, respectively.  
Second exercise training period 
Non-responders to the first ET period subsequently performed a second ET 
intervention including 2 additional training sessions per week. Paired comparisons 
were performed after the second ET period versus baseline (prior to the first ET 
period) in non-responder individuals, thus assessing the total impact of both training 
periods in each group (n = 11, ‗1 + 2‘; n = 6, ‗2 +2‘; n = 4, ‗3 + 2‘). Body weight 
decreased in group ‗2 + 2‘ (P < 0.05). Hbmass, RBCV, BV, VO2max and Wmax increased in 
all groups (‗1 + 2‘, ‗2 +2‘, ‗3 + 2‘) (P < 0.05). MitoVD was not assessed after the second 
ET period. Analyses with percentage (instead of Δ) changes and/or without covariate 
adjustment gave similar results. Figure 2 displays individual percentage changes in 
Wmax after the first and second ET periods for non-responders individuals. Non-
response was not observed after the second ET period in any individual. 
Determinants of changes in ∆Wmax and ∆VO2max 
In univariate analysis, ∆VO2max (r = 0.85, P < 0.001), ∆Hbmass (r = 0.64, P < 0.001), 
∆RBCV (r = 0.62, P < 0.001), ∆BV (r = 0.53, P < 0.001), ∆PV (r = 0.42, P < 0.001) and 
∆MitoVD (r = 0.26, P = 0.043) and were positively whereas ∆body weight (r = -0.29, P 
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= 0.003) negatively associated with ∆Wmax. Moreover, ∆Hbmass (r = 0.64, P < 0.001), 
∆RBCV (r = 0.62, P < 0.001), ∆BV (r = 0.52, P < 0.001) and ∆PV (r = 0.42, P < 0.001) 
were positively and ∆body weight (r = -0.25, P = 0.012) negatively associated with 
∆VO2max. Accordingly, ∆Hbmass, ∆RBCV, ∆PV, ∆BV, ∆MitoVD, ∆VO2max and ∆body 
weight were entered into the regression model as potential independent 
determinants of ∆Wmax (Table 3), while ∆Hbmass, ∆RBCV, ∆PV, ∆BV and ∆body weight 
were entered as potential independent determinants of ∆VO2max (Table 4).  ∆VO2max 
remained the only variable independently associated with ∆Wmax (β = 0.08, rpartial ≥ 
0.74, P < 0.001). In turn, ∆Hbmass was the strongest independent determinant 
∆VO2max (β = 3.26, rpartial = 0.49, P < 0.001). 
Discussion 
The present study tested the prevalence of CRF non-response, as defined by any 
change of Wmax not surpassing %TE, with a double 6-week ET protocol in 78 healthy 
individuals. The key findings are: 1) after the first ET period, the prevalence of CRF 
non-response was 69, 40 and 29 % in individuals training for 60, 120 or 180 min per 
week, respectively, and was absent (0 %) in those training for 240 or 300 min per 
week; 2) CRF non-response was completely eliminated following the second 6-week 
ET period including 2 extra 60 min sessions per week; and 3) CRF (non-)response was 
underlay by changes in Hbmass. 
While the existence of interindividual response variability to exercise training is 
beyond dispute, less convincing is the generalized idea that a substantial fraction 
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(~20 %) of individuals fail to improve CRF  following intense ET (Timmons et al., 
2010). Supporting evidence primarily derives from HERITAGE, in which 473 Caucasian 
adults (51 % females) completed 3 exercise sessions per week progressively 
increasing their length from 30 to 50 min and intensity from 55 % to 75 % of 
maximal heart rate (HRmax), during 5 months (Bouchard et al., 1995; Timmons et al., 
2010). The HERITAGE ET program thus reached the low end of current 
recommendations as regards exercise time per week (150 min) and did not comprise 
high intensity exercise (≥ 80 % HRmax) (Garber et al., 2011). Of note, since exercise 
intensity was controlled by heart rate monitoring, interindividual fluctuations in 
training workload did occur and partly explained VO2max responses to ET in HERITAGE 
(Sarzynski et al., 2016). Most importantly, meta-analytical evidence encompassing 
research performed during the last 4 decades suggests that higher doses of ET than 
those prescribed in HERITAGE can generate substantial improvements in VO2max in 
nearly all young and middle-aged adults (Bacon et al., 2013). Likewise, recent studies 
have observed gradual decreases in the number of CRF non-responders with 
increasing doses of ET in individuals who completed ≥ 90 % of the exercise sessions 
prescribed (Sisson et al., 2009; Ross et al., 2015). A key limitation of these studies, 
however, is the potential presence of CRF non-responders in individuals who 
dropped out or failed to complete the minimum number of exercise sessions. 
Definitive proof that CRF non-responders may benefit from higher ET doses can only 
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be provided by within-subject study designs (Mann et al., 2014; Hecksteden et al., 
2015), as originally applied in the current study and discussed hereunder.  
We sought to determine CRF trainability with a repeated 6-week ET intervention 
combining moderate continuous with high intensity exercise intervals in 60 min 
sessions. In the first ET period, individuals from 5 groups only differing in the number 
of sessions (1 to 5) and thus exercise dose per week were compared. In more than 20 
% of individuals allocated to 1 (60 min), 2 (120 min) or 3 (180 min) sessions of ET per 
week, Wmax did not increase (-1, -1 and 2 %, respectively) more than 1 × %TE (4 %) 
and hence they were considered as CRF non-responders. Afterwards, CRF non-
responders accomplished a second ET period including 2 x 60 min additional 
sessions per week of otherwise identical training. After this additional training period 
CRF non-response was no longer present in any individual. This unequivocally 
demonstrates that CRF non-response was not inexorably predetermined in the study 
subjects and suggests that the potential for CRF improvements might well be present 
and unveiled with appropriate stimuli in healthy individuals without exception. Such 
unanimous CRF response may also indicate a relatively minor influence of within-
subject response variability and measurement error when applying successive higher 
doses of ET (Bacon et al., 2013; Hecksteden et al., 2015).  
Despite our data clearly denote the spurious nature of CRF non-response, a wide 
interindividual variability in CRF improvements to identical ET dose is plainly 
illustrated in Figures 1 and 2. Certainly, hereditary factors must be assumed to play a 
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role on CRF trainability (Bouchard et al., 1999), although family- and large 
population-based confirmatory/replication studies are needed (Thomis, 2008). In 
addition, an often overlooked factor is the typical use of some percentage of HRmax, 
VO2max or Wmax to prescribe exercise intensity, which does not effectively standardize 
the homeostatic stress caused by ET at the individual level (Meyer et al., 1999; Gaskill 
et al., 2001; Scharhag-Rosenberger et al., 2010). Therefore, provided a given ET dose, 
individuals may experience diverse magnitudes of stimuli for adaptive responses. 
Furthermore, a perfectly identical exercise dose prescription for any individual may 
prompt distinct homeostatic stress according to its interaction with oscillating factors 
such as sleep and nutrition, both affecting recovery and readiness to train (Kentta & 
Hassmen, 1998; Samuels, 2009; Hawley et al., 2011). Collectively considered, a 
comparable homeostatic stress among individuals involved in ET, as commonly 
prescribed, seems unlikely (Mann et al., 2014). It follows that a certain degree of 
interindividual variability in CRF trainability to a fixed ET dose may be generally 
expected by default due to lack of truly standardized exercise stimuli. 
The question arises as to whether variability in CRF response to ET lie upon firm 
mechanistic bases. ET is commonly associated with a surfeit of phenotypic 
modifications along the O2 transport and utilization chain —from lung to 
mitochondria—, all potentially contributing to VO2max and Wmax improvements via 
enhancing convective oxygen delivery to and/or extraction by active tissue (Hawley 
& Noakes, 1992; Helgerud et al., 2007; Boushel et al., 2011; Lundby & Montero, 2015; 
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Montero et al., 2015a; Wagner, 2015). The bulk of evidence indicates that 
haemodynamic and haematological systemic adaptations increasing the capacity to 
deliver oxygen predominantly explain VO2max improvements with short-term (5-11 
weeks) ET in healthy individuals (Montero & Diaz-Canestro, 2015; Montero et al., 
2015b). Empirical evidence demonstrates that the increase in VO2max with 6 weeks of 
moderate-to-high intensity ET is primarily attributed to augmented circulating RBCV 
and oxygen-carrying capacity of blood, as reflected by increases in total circulating 
Hbmass (Bonne et al., 2014; Montero et al., 2015a). In turn, increases in skeletal muscle 
capillarization and MitoVD, both possibly facilitating oxygen extraction, do not seem 
to contribute substantially to the increase in VO2max after 6 weeks of ET (Montero et 
al., 2015a). Concurring with the above, in the present study increases (∆) in Hbmass 
were the strongest determinants of ∆VO2max, which in turn explained most of the 
variance in ∆Wmax. Yet, approximately half of the variance in ∆VO2max remained 
unexplained, which could be partially attributed to non-assessed adaptations 
modulating cardiac output and its distribution (Boushel et al., 2014; Lundby et al., 
2016). The parallelism between changes in VO2max and underlying phenotypic 
modifications measured in this study implies the presence of quantitative but not 
major qualitative differences in either homeostatic stress induced by ET or adaptive 
capacity on an individual basis.  Ultimately, it is worth noticing that the genetic bases 
of crucial physiological pathways governing convective oxygen delivery have not 
been identified (Sarzynski et al., 2016). 
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Another important outcome of this study was the magnitude of increases in CRF at 
the group level according to ET dose. Increases in Wmax with 240 or 300 min were 
substantial (24 and 32 %) and higher compared with uniformly small Wmax changes 
observed with 60, 120 or 180 min of training per week (1, 5 and 7 %, respectively) 
(Figure 1). Similar findings were found regarding VO2max (Figure 3). Part of this gap 
could be attributed to lower Hbmass in the 300 min group prior to ET (P = 0.064) 
facilitating greater adaptations, albeit baseline values were included as covariates. 
Regardless, the critical duration of exercise for CRF improvements with moderate-
high intensity ET may lie somewhere between > 180 ≤ 240 min per week for most 
individuals. This finding concurs with previous reports suggesting to raise the 
minimum level of exercise dose in physical activity guidelines for healthy adults 
(Bacon et al., 2013; Ross et al., 2015).  
Limitations 
Findings were obtained from a sample of healthy young males. Further research will 
elucidate whether current conclusions can be extrapolated to populations including 
females, older individuals and/or cardio-metabolic patients. Moreover, this study was 
designed to dissect the independent contribution of overall ET dose, but not of its 
components (frequency/length of exercise sessions, total duration, intensity). In 
addition, VO2max measurements were not duplicated at baseline and therefore %TE 
for VO2max was not calculated. Nonetheless, VO2max and Wmax responses were closely 
associated and all Wmax non-responders increased their VO2max with higher ET dose 
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(Figures 3 and 4). Finally, changes in body composition potentially influencing CRF 
were not assessed.  
Conclusion 
This study fundamentally challenges the notion of CRF non-response to exercise 
training. In 78 healthy individuals performing moderate-to-high intensity ET for 6 
weeks, the prevalence of CRF non-response, as determined by Wmax, gradually 
declined in individuals exercising 60, 120 or 180 min per week.  No vestige of Wmax 
non-response was observed in individuals training 240 or 300 min per week. 
Following a successive 6-week ET period comprising 120 min of additional ET per 
week, Wmax non-response was universally abolished. Consistent with sound 
experimental evidence, haematological adaptations in oxygen-carrying capacity 
underlay VO2max and thereby Wmax (non-)responses to ET. These findings highlight 
the need to re-evaluate contemporary concepts about human untrainability and 
exercise prescription.  
Table 1. Baseline characteristics of study groups (n = 78) 
 Exercise sessions per week   
 1 (n=16) 2 (n=15) 3 (n=14) 4 (n=17) 5 (n=16)  ANOVA
 
Body weight  (kg) 76.6 ± 5.8 76.8 ± 4.8 77.7 ± 5.7 77.8 ± 8.8 79.8 ± 5.9  0.654 
Hct (%) 43.8 ± 2.3 43.4 ± 1.6 43.9 ± 2.1 43.0 ± 1.6 43.5 ± 2.2  0.752 
Hb (g·dl
-1
) 14.6 ± 0.7 14.4 ± 0.6 14.9 ± 0.7 14.8 ± 0.6 14.5 ± 0.8  0.229 
Hbmass (g) 847 ± 84 878 ± 151 826 ± 103 841 ± 113 761 ± 101  0.064 
PV (ml) 3266 ± 532 3440 ± 501 3077 ± 376 3246 ± 453 2976 ± 430  0.065 
RBCV (ml) 2521 ± 262 2640 ± 452 2408 ± 299 2454 ± 362 2288 ± 301  0.070 
BV (ml) 5787 ± 772 6080 ± 935 5486 ± 637 5700 ± 792 5264 ± 696  0.054 
MitoVD (%)
a 
4.62 ± 1.42 4.80 ± 1.14 4.89 ± 1.09 3.86 ± 0.91 4.32 ± 1.21  0.169 
HRmax (bpm) 188 ± 5 185 ± 7 187 ± 7 188 ± 6 187 ± 7  0.736 
RERmax 1.15 ± 0.05 1.15 ± 0.09 1.17 ± 0.06 1.13 ± 0.05 1.14 ± 0.07  0.510 
VO2max (ml·min
-1
) 3214 ± 507 3412 ± 736 3376 ± 438 3449 ± 514 2956 ± 435  0.069 
  
 
This article is protected by copyright. All rights reserved. 
22 
 
VO2max (ml·min
-1
·kg
-
1
) 42.4 ± 8.5 44.7 ± 10.7 43.4 ± 4.2 44.5 ± 5.8 37.4 ± 7.5 
 
0.057 
Wmax (W) 269 ± 44  289 ± 66 297 ± 42 266 ± 48 239 ± 40
3  0.015 
Wmax (W·kg
-1
) 3.54 ± 0.70 3.80 ± 0.95 3.82 ± 0.45 3.42 ± 0.48 3.02 ± 0.61
23  0.008 
BV, blood volume; Hbmass, hemoglobin mass; Hct, 
haematocrit; HRmax, maximal heart rate; MitoVD, 
mitochondrial volume density; PV, plasma volume; 
RBCV, red blood cell volume; RERmax, maximal 
respiratory exchange ratio; VO2max, maximal oxygen 
consumption; Wmax, maximal power output.  
Superscript numbers (1, 2, 3, 4, 5) correspond to 
differences (P < 0.05) between groups (‗1‘, ‗2‘, ‗3‘, ‗4‘, 
‗5‘). 
 
a
 MitoVD values were not available in all study 
subjects (sample size of 15, 14, 11, 15, 14 in groups 
‗1‘, ‗2‘, ‗3‘, ‗4‘ and ‗5‘, respectively). 
Table 2. Absolute changes (∆) after the first exercise training period 
 Exercise sessions per week   
 1 (n=16) 2 (n=15) 3 (n=14) 4 (n=17) 5 (n=16)  ANOVA
a 
∆Body weight (kg) -0.21±1.26 -0.23±0.94 -0.39±1.96 -1.38±1.96* 
-
2.75±0.98*
123
 
 
<0.001 
∆Hct (%) 0.03±1.15 -0.31±1.28 -0.91±2.64 -1.33±1.31* 0.20±1.24
4
  0.024 
∆Hb (g·dl
-1
) 0.03±0.38 -0.04±0.43 -0.18±0.65 -0.10±0.56 -0.00±0.42  0.919 
∆Hbmass (g) 15.6±39.4 40.0±43.6* 34.3±35.8* 44.9±40.4* 137±51.7*
1234
  <0.001 
∆PV (ml) 31±294 203±206* 263±386* 55±253 555±250*
124
  <0.001 
∆RBCV (ml) 28±150 108±129* 105±99* 177±147*
1
 398±158*
1234
  <0.001 
∆BV (ml) 59±429 311±296* 368±446* 232±371* 953±376*
1234
  <0.001 
∆MitoVD (%)
b 
0.48±0.27* 0.74±0.43* 1.66±0.50*
1
 2.15±1.18*
12
 1.92±1.32*
12
  <0.001 
∆VO2max (ml·min
-1
) 27±161 152±178* 156±174* 424±207*
123
 707±311*
1234
  <0.001 
∆VO2max (ml·min
-1
·kg
-
1
) 0.42±2.40 2.19±2.39* 2.47±1.90* 6.50±2.98*
123
 
10.49±3.9*
123
4
 
 
<0.001 
∆Wmax (W) 3.13±12.65  13.13±17.4* 21.18±12.3* 63.37±24.6*
123
 75.75±31.3*
123
  <0.001 
∆Wmax (W·kg
-1
) 0.05±0.17 0.19±0.23* 0.30±0.16* 0.92±0.39*
123
 1.09±0.40*
123
  <0.001 
BV, blood volume; Hbmass, hemoglobin mass; Hct, 
haematocrit; MitoVD, mitochondrial volume density; PV, 
plasma volume; RBCV, red blood cell volume; VO2max, 
maximal oxygen consumption; Wmax, maximal power 
output; ∆, post minus pre training absolute change.   
 
* P < 0.05 post training versus pre training. 
Superscript numbers (1, 2, 3, 4, 5) correspond to 
differences (P < 0.05) between groups (‗1‘, ‗2‘, ‗3‘, ‗4‘, ‗5‘). 
 
a
 Baseline values included as covariates. 
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b
 MitoVD values were not available in all study subjects 
(sample size of 13, 12, 9, 15, 12 in groups ‗1‘, ‗2‘, ‗3‘, ‗4‘ 
and ‗5‘, respectively). 
Table 3. Multiple linear regression with ∆Wmax as the dependent variable  
Model 
 
β (95 % CI) rpartial P
 
Adjusted R
2 
P 
1.       
∆Body weight (kg)  -0.001 (-0.004, 0.001) -0.137 0.307 0.72 <0.001 
∆Hbmass (g)  0.072 (-0.062, 0.207) 0.142 0.287   
∆PV (ml)  0.003 (-0.017, 0.022) 0.035 0.797   
∆MitoVD (%)  2.170 (-1.979, 6.318) 0.139 0.299   
∆VO2max (ml)  0.080 (0.060, 0.100) 0.738 <0.001   
2. (including RBCV instead of Hbmass)     
∆Body weight (kg)  -0.002 (-0.005, 0.001) -0.158 0.235 0.72 <0.001 
∆RBCV (ml)  0.023 (-0.020, 0.067) 0.143 0.283   
∆PV (ml)  0.023 (-0.020, 0.067) 0.143 0.283   
∆MitoVD (%)  1.988 (-2.256, 6.232) 0.124 0.352   
∆VO2max (ml·min
-1
)  0.080 (0.061, 0.100) 0.742 <0.001   
3. (including BV instead of Hbmass, PV and RBCV)     
∆Body weight (kg)  -0.002 (-0.004, 0.001) -0.166 0.210 0.73 <0.001 
∆BV (ml)  0.008 (-0.003, 0.019) 0.181 0.170   
∆MitoVD (%)  2.462 (-1.569, 6.492) 0.160 0.226   
∆VO2max (ml·min
-1
)  0.083 (0.065, 0.101) 0.773 <0.001   
β, unstandardized regression coefficient with Wmax (W) 
as outcome; BV, blood volume; CI, confidence interval; 
Hbmass, hemoglobin mass; MitoVD, mitochondrial 
volume density; PV, plasma volume; RBCV, red blood 
cell volume; rpartial, partial correlation coefficient; VO2max, 
maximal oxygen consumption; Wmax, maximal power 
output; ∆, post minus pre training absolute change.  
∆Hbmass, ∆RBCV and ∆PV were closely correlated with 
∆BV in bivariate analyses (r > 0.80, P < 0.0001), thus 
these variables were appropriately entered into a 
regression model in order to avoid high 
multicollinearity (VIF >10). 
Table 4. Multiple linear regression with ∆VO2max as the dependent variable  
Model 
 
β (95 % CI) rpartial P
 
Adjusted R
2 
P 
1.       
∆Body weight (kg)  -0.021 (-0.051, 0.008) -0.147 0.153 0.41 <0.001 
∆Hbmass (g)  3.262 (2.076, 4.448) 0.491 <0.001   
∆PV (ml)  0.015 (-0.019, 0.219) 0.015 0.884   
2. (including RBCV instead of Hbmass)     
∆Body weight (kg)  -0.032 (-0.061, - -0.218 0.033 0.39 <0.001 
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0.002) 
∆RBCV (ml)  1.002 (0.620, 1.384) 0.473 <0.001   
∆PV (ml)  -0.031 (-0.253, 0.191) -0.029 0.884   
3. (including BV instead of Hbmass, PV and RBCV)     
∆Body weight (kg)  
-0.042 (-0.072, -
0.012) -0.273 0.007 0.31 <0.001 
∆BV (ml)  0.330 (0.223, 0.436) 0.531 <0.001   
β, unstandardized regression coefficient with VO2max 
(ml) as outcome; BV, blood volume; CI, confidence 
interval; Hbmass, hemoglobin mass; PV, plasma volume; 
RBCV, red blood cell volume; rpartial, partial correlation 
coefficient; VO2max, maximal oxygen consumption; ∆, 
post minus pre training absolute change. 
∆Hbmass, ∆RBCV and ∆PV were closely correlated with 
∆BV in bivariate analyses (r > 0.80, P < 0.0001), thus 
these variables were appropriately entered into a 
regression model in order to avoid high 
multicollinearity (VIF >10). 
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Figure 1. Individual percentage changes in maximal power output (Wmax) after the 
first exercise training period in each group. The typical error of measurement (%TE) 
for Wmax measurement is illustrated by the shaded area. Values within this area 
represent non-response. Non-response was 69 % (11 of 16), 40 % (6 of 15), 29 % (4 
of 14), 0 % (0 out of 17) and 0 % (0 out of 16) for ‗1‘, ‗2‘, ‗3‘, ‗4‘ and ‗5‘ groups, 
respectively. 
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Figure 2. Individual percentage changes in maximal power output (Wmax) after the 
second exercise training period for non-responders in each group. The typical error 
of measurement (%TE) for Wmax measurement is illustrated by the shaded area. 
Values within this area represent non-response. Non-response was abolished after 
the second exercise training period in all individuals. 
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Figure 3. Individual percentage changes in maximal oxygen consumption (VO2max) 
after the first exercise training period in each group. 
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Figure 4. Individual percentage changes in maximal oxygen consumption (VO2max) 
after the second exercise training period for non-responders (according to changes 
in maximal power output (Wmax)) in each group. 
 
 
